Dynamics of the Skeletal Muscle Secretome during Myoblast Differentiation*

During recent years, increased efforts have focused on elucidating the secretory function of skeletal muscle. Through secreted molecules, skeletal muscle affects local muscle biology in an auto/paracrine manner as well as having systemic effects on other tissues. Here we used a quantitative proteomics platform to investigate the factors secreted during the differentiation of murine C2C12 skeletal muscle cells. Using triple encoding stable isotope labeling by amino acids in cell culture, we compared the secretomes at three different time points of muscle differentiation and followed the dynamics of protein secretion. We identified and quantitatively analyzed 635 secreted proteins, including 35 growth factors, 40 cytokines, and 36 metallopeptidases. The extensive presence of these proteins that can act as potent signaling mediators to other cells and tissues strongly highlights the important role of the skeletal muscle as a prominent secretory organ. In addition to previously reported molecules, we identified many secreted proteins that have not previously been shown to be released from skeletal muscle cells nor shown to be differentially released during the process of myogenesis. We found 188 of these secreted proteins to be significantly regulated during the process of myogenesis. Comparative analyses of selected secreted proteins revealed little correlation between their mRNA and protein levels, indicating pronounced regulation by posttranscriptional mechanisms. Furthermore, analyses of the intracellular levels of members of the semaphorin family and their corresponding secretion dynamics demonstrated that the release of secreted proteins is tightly regulated by the secretory pathway, the stability of the protein, and/or the processing of secreted proteins. Finally, we provide 299 unique hydroxyproline sites mapping to 48 distinct secreted proteins and have discovered a novel hydroxyproline motif.

[1]  B. K. Pedersen The diseasome of physical inactivity – and the role of myokines in muscle–fat cross talk , 2009, The Journal of physiology.

[2]  B. Pedersen Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. , 2009, Journal of applied physiology.

[3]  Blagoy Blagoev,et al.  Receptor tyrosine kinase signaling: a view from quantitative proteomics. , 2009, Molecular bioSystems.

[4]  B. Pedersen,et al.  Fibroblast Growth Factor-21 Is Induced in Human Skeletal Muscles by Hyperinsulinemia , 2009, Diabetes.

[5]  L. McLoon A new role for satellite cells: control of reinnervation after muscle injury by semaphorin 3A. Focus on "Possible implication of satellite cells in regenerative motoneuritogenesis: HGF upregulates neural chemorepellent Sema3A during myogenic differentiation". , 2009, American journal of physiology. Cell physiology.

[6]  Judy E. Anderson,et al.  Possible implication of satellite cells in regenerative motoneuritogenesis: HGF upregulates neural chemorepellent Sema3A during myogenic differentiation. , 2009, American journal of physiology. Cell physiology.

[7]  J. Kapfhammer,et al.  A PKC-Dependent Recruitment of MMP-2 Controls Semaphorin-3A Growth-Promoting Effect in Cortical Dendrites , 2009, PloS one.

[8]  M. Walker,et al.  Insulin-like growth factor I (IGF-I) is a more potent regulator of gene expression than insulin in primary human myoblasts and myotubes. , 2009, Growth Hormone & IGF Research.

[9]  B. Loos,et al.  TGF-beta's delay skeletal muscle progenitor cell differentiation in an isoform-independent manner. , 2009, Experimental cell research.

[10]  J. Wylie-Rosett,et al.  The role of insulin‐like growth factor‐I and its binding proteins in glucose homeostasis and type 2 diabetes , 2009, Diabetes/metabolism research and reviews.

[11]  D. Hittel,et al.  Increased Secretion and Expression of Myostatin in Skeletal Muscle From Extremely Obese Women , 2009, Diabetes.

[12]  Y. Choi,et al.  Comparative proteomic analysis of the insulin‐induced L6 myotube secretome , 2009, Proteomics.

[13]  K. Walsh Adipokines, myokines and cardiovascular disease. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[14]  Jürgen Cox,et al.  A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics , 2009, Nature Protocols.

[15]  S. Šatkauskas,et al.  The many faces of semaphorins: from development to pathology , 2009, Cellular and Molecular Life Sciences.

[16]  M. Mann,et al.  Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast , 2008, Nature.

[17]  E. Brandan,et al.  Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy. , 2008, Matrix biology : journal of the International Society for Matrix Biology.

[18]  M. Febbraio,et al.  Muscle as an endocrine organ: focus on muscle-derived interleukin-6. , 2008, Physiological reviews.

[19]  P. Yin,et al.  IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop , 2008, The Journal of cell biology.

[20]  Tobias Straub,et al.  Combined use of RNAi and quantitative proteomics to study gene function in Drosophila. , 2008, Molecular cell.

[21]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[22]  Kazuki Nakamura,et al.  Inhibition of matrix metalloproteinases suppresses the migration of skeletal muscle cells , 2008, Journal of Muscle Research and Cell Motility.

[23]  Mariana Salimena,et al.  Pattern of metalloprotease activity and myofiber regeneration in skeletal muscles of mdx mice , 2008, Muscle & nerve.

[24]  S. Krane,et al.  The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens , 2008, Amino Acids.

[25]  R. Pasterkamp,et al.  Semaphorin signaling: progress made and promises ahead. , 2008, Trends in biochemical sciences.

[26]  J. C. McDermott,et al.  Transforming growth factor-β and myostatin signaling in skeletal muscle , 2008 .

[27]  M. Mann,et al.  Dissection of the insulin signaling pathway via quantitative phosphoproteomics , 2008, Proceedings of the National Academy of Sciences.

[28]  G. Pavlath,et al.  Molecular control of mammalian myoblast fusion. , 2008, Methods in molecular biology.

[29]  E. Wilson,et al.  Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions. , 2008, Molecular endocrinology.

[30]  J. C. McDermott,et al.  Transforming growth factor-beta and myostatin signaling in skeletal muscle. , 2008, Journal of applied physiology.

[31]  S. Tågerud,et al.  Semaphorin 6C expression in innervated and denervated skeletal muscle , 2008, Journal of Molecular Histology.

[32]  Xiaozhong Peng,et al.  Sema4C participates in myogenic differentiation in vivo and in vitro through the p38 MAPK pathway. , 2007, European journal of cell biology.

[33]  Lokesh Kumar,et al.  Mfuzz: A software package for soft clustering of microarray data , 2007, Bioinformation.

[34]  D. Judge,et al.  Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states , 2007, Nature Medicine.

[35]  Christopher M Overall,et al.  Proteomics Discovery of Metalloproteinase Substrates in the Cellular Context by iTRAQ™ Labeling Reveals a Diverse MMP-2 Substrate Degradome*S , 2007, Molecular & Cellular Proteomics.

[36]  J. Gutkind,et al.  MT1-MMP Controls Tumor-induced Angiogenesis through the Release of Semaphorin 4D* , 2007, Journal of Biological Chemistry.

[37]  W. Stauber,et al.  Transforming growth factor-β following skeletal muscle strain injury in rats , 2007 .

[38]  J. C. McDermott,et al.  Identification of secreted proteins during skeletal muscle development. , 2007, Journal of proteome research.

[39]  M. Mann,et al.  In-gel digestion for mass spectrometric characterization of proteins and proteomes , 2006, Nature Protocols.

[40]  W. Stauber,et al.  Transforming growth factor-beta following skeletal muscle strain injury in rats. , 2007, Journal of applied physiology.

[41]  M. Mann,et al.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips , 2007, Nature Protocols.

[42]  D. Aunis,et al.  Functional interaction between matrix metalloproteinase-3 and semaphorin-3C during cortical axonal growth and guidance , 2006, International Journal of Developmental Neuroscience.

[43]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[44]  Blagoy Blagoev,et al.  Quantitative proteomics to study mitogen-activated protein kinases. , 2006, Methods.

[45]  E. Brandan,et al.  Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[46]  M. Mann,et al.  Parts per Million Mass Accuracy on an Orbitrap Mass Spectrometer via Lock Mass Injection into a C-trap*S , 2005, Molecular & Cellular Proteomics.

[47]  S. Mohan,et al.  Pregnancy-associated Plasma Protein-A Regulates Myoblast Proliferation and Differentiation through an Insulin-like Growth Factor-dependent Mechanism* , 2005, Journal of Biological Chemistry.

[48]  N. Rosenthal,et al.  IGF-1, inflammation and stem cells: interactions during muscle regeneration. , 2005, Trends in immunology.

[49]  S. Tapscott,et al.  MyoD and the transcriptional control of myogenesis. , 2005, Seminars in cell & developmental biology.

[50]  Giorgio F. Gilestro,et al.  Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis. , 2005, Cancer research.

[51]  R. Norton,et al.  IGF-binding proteins – the pieces are falling into place , 2005, Trends in Endocrinology & Metabolism.

[52]  F. Saltel,et al.  Expression and function of semaphorin 7A in bone cells , 2005, Biology of the cell.

[53]  S. Tapscott,et al.  The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription , 2005, Development.

[54]  W. Kaelin,et al.  Proline hydroxylation and gene expression. , 2005, Annual review of biochemistry.

[55]  Blagoy Blagoev,et al.  Mechanism of Divergent Growth Factor Effects in Mesenchymal Stem Cell Differentiation , 2005, Science.

[56]  T. Motyl,et al.  Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts. , 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[57]  C. Duan,et al.  Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. , 2005, General and comparative endocrinology.

[58]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[59]  C. Holding,et al.  Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Rudnicki,et al.  Cellular and molecular regulation of muscle regeneration. , 2004, Physiological reviews.

[61]  J. D. Wit,et al.  Role of semaphorins in the adult nervous system , 2003, Progress in Neurobiology.

[62]  B. Wentworth,et al.  Characterization of proliferating human skeletal muscle‐derived cells in vitro: Differential modulation of myoblast markers by TGF‐β2 , 2003, Journal of cellular physiology.

[63]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[64]  K. Kristiansen,et al.  A Proteomic Approach for Identification of Secreted Proteins during the Differentiation of 3T3-L1 Preadipocytes to Adipocytes* , 2002, Molecular & Cellular Proteomics.

[65]  A. Saltiel You are what you secrete , 2001, Nature Medicine.

[66]  T. Hawke,et al.  Myogenic satellite cells: physiology to molecular biology. , 2001, Journal of applied physiology.

[67]  A. Elhabazi,et al.  Biological Activity of Soluble CD100. I. The Extracellular Region of CD100 Is Released from the Surface of T Lymphocytes by Regulated Proteolysis1 , 2001, The Journal of Immunology.

[68]  B. Saltin,et al.  Production of interleukin‐6 in contracting human skeletal muscles can account for the exercise‐induced increase in plasma interleukin‐6 , 2000, The Journal of physiology.

[69]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[70]  S. Ferrari,et al.  Inhibition of myogenesis by transforming growth factor beta is density-dependent and related to the translocation of transcription factor MEF2 to the cytoplasm. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[71]  M. Lohrum,et al.  The chemorepulsive activity of secreted semaphorins is regulated by furin‐dependent proteolytic processing , 1997, The EMBO journal.

[72]  K. Koishi,et al.  Cellular localisation of transforming growth factor‐beta 2 and ‐beta 3 (TGF‐β2, TGF‐β3) in damaged and regenerating skeletal muscles , 1997 .

[73]  K. Koishi,et al.  Cellular localisation of transforming growth factor-beta 2 and -beta 3 (TGF-beta2, TGF-beta3) in damaged and regenerating skeletal muscles. , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[74]  C. Stewart,et al.  Insulin-like Growth Factor-II Is an Autocrine Survival Factor for Differentiating Myoblasts (*) , 1996, The Journal of Biological Chemistry.

[75]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[76]  P. Rotwein,et al.  A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. , 1993, The Journal of biological chemistry.

[77]  J. Massagué,et al.  Transforming growth factor beta induces myoblast differentiation in the presence of mitogens. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[78]  J R Florini,et al.  "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. , 1991, The Journal of biological chemistry.

[79]  M. Sporn,et al.  Secretion and transcriptional regulation of transforming growth factor-beta 3 during myogenesis , 1991, Molecular and cellular biology.